Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Schneyer Mark C., Chief Financial Officer. Director active across 1 company, notably Acadia Pharmaceuticals INC. Cumulatively, 45 filings have been recorded. Breakdown: 0 buy · 17 sells. Total volume traded: €2m. Activity tracked since 23 February 2022. The latest transaction was filed on 6 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Schneyer Mark C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9,733 shares@ US$15.288.9% of flowCommon StockSEC:0001415889-24-021731:2
25 of 45 declarations
About Schneyer Mark C.
Schneyer Mark C. is Directeur Financier at Acadia Pharmaceuticals INC, where he is EVP, CHIEF FINANCIAL OFFICER. He has 40 filings in total, and in the most recent filings available there were only sales for a total of EUR 1502572, over the period from 2022-02-25 to 2026-05-05.